Biotech & Pharma
Health Tech
Business & Policy
Health & Science
Team
Exclusive analysis of biotech, pharma, and the life sciences
Topics
Columns
Tools
Events
Team
Account
More
Follow Us
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
from some of the nation’s most trusted and well-connected journalists
hosted by STAT+, plus early access and discounts to can’t-miss industry gatherings
delivered to your inbox with the latest market-moving news and insights
that help you stay up to date with the latest research and developments
on the technologies, personalities, power brokers, and political forces driving changes in life science
plus early access and discounts to industry gatherings
delivered straight to your inbox with the latest industry news
that help you stay up to date with industry research and developments
for the latest news and insights in the world of life sciences, medicine, biotech, and pharma
at exclusive live and virtual events hosted by STAT
with subscriber-only newsletters delivered to your inbox daily
with our premium data tools
By Mario Aguilar Dec. 6, 2022
In a significant victory, Apple has successfully challenged patents at the center of a high-profile dispute with medical device company AliveCor.
The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board, or PTAB, on Tuesday ruled that three AliveCor patents covering heart monitoring technologies for wearable devices were unpatentable. AliveCor alleged in federal court and before the International Trade Commission that Apple had copied the technologies with its Apple Watch, and over the summer an ITC judge found that Apple had infringed on two of three patents AliveCor asserted in its complaint.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
Health Tech Correspondent
Mario Aguilar covers how technology is transforming health care.
cardiology
health tech
This name will appear with your comment
There was an error saving your display name. Please check and try again.
advertisement
Reporting from the frontiers of health and medicine
You’ve been selected! Subscribe to STAT+ for less than $2 per day
Unlimited access to essential biotech, medicine, and life sciences journalism
Subscribe to STAT+ for less than $2 per day
Unlimited access to the health care news and insights you need
Subscribe to STAT+ for less than $2 per day
Unlimited access to essential biotech, medicine, and life sciences journalism